Grant: Rapid Funding for DSEN Targeted Research - Prospective Studies
Research Institute of the McGill University Health Centre
$495,000.00
CAN-AIM Team DSEN Targeted Research Prospective Studies
FY 2012-13
Summary
Our CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research (CAN-AIM) team was
recently funded by the Canadian Institutes of Health Research (CIHR) to develop novel methods, using prospective
longitudinal cohorts, to study drug safety and effectiveness. The funding was provided through the Drug Safety and
Effectiveness Network (DSEN), established at CIHR as part of the Government of Canada's Food and Consumer Safety
Action Plan. CIHR has been working jointly with Health Canada, along with stakeholders from across Canada, to develop the
Drug Safety and Effectiveness Network. In Canada (and in fact worldwide), there are key knowledge gaps regarding the
safety and effectiveness of drugs used in the real-world. The DSEN has asked CAN-AIM and the other network-funded
teams, to respond to queries on drug safety and efficacy, which arise from Health Canada and other regulatory parties.
Department
Program
Rapid Funding for DSEN Targeted Research - Prospective Studies
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
278156
Name
Bernatsky Sasha R
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Rapid Funding for DSEN Targeted Research
Projecttitle
CAN-AIM Team DSEN Targeted Research Prospective Studies
Programtype2
Miscellaneous Programs
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$495,000
Cihrequipment2
$5,000
Programname2
Rapid Funding for DSEN Targeted Research - Prospective Studies
Keyworddelim
Anti-Depressant Medications And Fractures; Anti-Hypertensive Therapy; Biostatistics; Cardiac Outcomes; Comparative Effectiveness Research; Diabetes Treatment And Outcomes; Drug Safety; Epidemiology; Longitudinal Analyses; Prospective Cohort
Abstract
Our CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research (CAN-AIM) team was
recently funded by the Canadian Institutes of Health Research (CIHR) to develop novel methods, using prospective
longitudinal cohorts, to study drug safety and effectiveness. The funding was provided through the Drug Safety and
Effectiveness Network (DSEN), established at CIHR as part of the Government of Canada's Food and Consumer Safety
Action Plan. CIHR has been working jointly with Health Canada, along with stakeholders from across Canada, to develop the
Drug Safety and Effectiveness Network. In Canada (and in fact worldwide), there are key knowledge gaps regarding the
safety and effectiveness of drugs used in the real-world. The DSEN has asked CAN-AIM and the other network-funded
teams, to respond to queries on drug safety and efficacy, which arise from Health Canada and other regulatory parties.
Competitiondate
201301
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bernatsky, Sasha R; Abrahamowicz, Michal M; Levesque, Linda E; Levy, Adrian R; Moride, Yola; Pilote, Louise; Rahme, Elham; Tamblyn, Robyn M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $495,000~ $5,000~
